Company news
IOL Chemicals & Pharmaceuticals has been awarded the CEP certification (Certificates of Suitability dated April 17) for metformin hydrochloride by the European Directorate for the Quali...06-05-2015
06-05-2015
CEP certification for product Metformin Hydrochloride by EDQM
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has been awarded with CEP certification (Certificates of Suitability) dated April 17, 2015 for its product Metformin Hydrochloride by European Directorate for the Quality of Medicines & Healthcare (EDQM) authorities, Council of Europe, France. The certificate is valid for a period of five years from the date of issue. Now, the Company is able to sell Metformin Hydrochloride in...05-05-2015
Closure of Trading Window
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that as per the Companys Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the Trading Window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the quarter/ year ended March 31, 2015 for all the Designated...15-04-2015
Shareholding Pattern For March 31, 2015
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.11-04-2015
Outcome of Independent Directors Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Independent Directors in their meeting held on March 30, 2015, inter alia, evaluated the performance of non-independent directors and the Board as a whole; evaluated the performance of the Chairman of the Company and assessed the quality, quantity and timeliness of flow of information between the Company management and the Board in line with the requirement of Clause 49 of the Listing Agreement...30-03-2015
Updates
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that 8,41,987 equity shares of the face value Rs. 10/- each which was allotted on November 28, 2014 on conversion of US $ one million bonds in the name of custodian on behalf of the bondholders, have been got transferred to those bondholder's beneficiary account from the custodian on February 13, 2015 as per their advice.14-02-2015
Financial Results & Limited Review for Dec 31, 2014 (Standalone)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.13-02-2015
Clarification
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that:"This has reference to the mail received today from ET NOW regarding the rumour about the company of making default on debt obligations with Punjab National Bank. In this regard the company have clarified to ET NOW that the account with Punjab National Bank is standard.This clarification is provided in the interest of the investors."06-02-2015
Shareholding Pattern For December 31, 2014
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.13-01-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
IOL Chemicals & Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199201-01-2015